Lotronex Tablet
Product Images NDC 54766-894

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lotronex (NDC 54766-894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lot00 0006 01)

Chemical structure diagram of alosetron hydrochloride, the active ingredient in LOTRONEX tablets. The diagram shows the molecular arrangement of atoms and bonds characteristic of alosetron hydrochloride.*

FDA Label Image

Figure 1 (Lot00 0006 02)

A bar graph comparing the percentage of patients responding to placebo versus LOTRONEX 1 mg twice daily (B.I.D.) across two sets of studies labeled as Studies 1 & 2 and Studies 3 & 4. The graph shows higher patient response percentages for LOTRONEX compared to placebo in both study groups.*

FDA Label Image

Principal Display Panel (Lotronex 0.5 mg Bottle Label)

Label for LOTRONEX 0.5 mg tablets containing alosetron hydrochloride. The label indicates a package of 30 film-coated tablets described as prescription drug with instructions to see prescribing information. It includes a blue tablet image marked 0.5 mg and states dispensing requires a Medication Guide. Distributed by Sebela Pharmaceuticals Inc., Roanoke, Georgia, made in Canada.*

FDA Label Image

Principal Display Panel (Lotronex 0.5 mg Carton)

Packaging label for LOTRONEX 0.5 mg tablets containing alosetron hydrochloride, distributed by Sebela Pharmaceuticals Inc. The label states each film-coated tablet contains 0.5 mg equivalent of alosetron, available in a 30 tablet count. The label includes storage instructions, NDC 54768-894-03, and notes dispensing with Medication Guide per Federal Law.*

FDA Label Image

Principal Display Panel (Lotronex 1 mg Bottle Label)

LOTRONEX (alosetron hydrochloride) 1 mg oral tablets label showing a package of 30 tablets. The label indicates the product is film-coated tablets, distributed by Sebela Pharmaceuticals Inc., made in Canada. It includes usage and storage recommendations and a barcode.*

FDA Label Image

Principal Display Panel (Lotronex 1 mg Carton)

LOTRONEX 1 mg tablets carton label featuring alosetron hydrochloride as the active ingredient. The oral film-coated tablets are prescription-only, supplied in a package of 30 tablets. The label shows the Sebela Pharmaceuticals Inc. distributor information and includes dosing details and a statement about the medication guide requirement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.